HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
100.47
-1.94 (-1.89%)
Dec 2, 2025, 3:30 PM EST - Market open
HealthEquity Stock Forecast
Stock Price Forecast
The 14 analysts that cover HealthEquity stock have a consensus rating of "Buy" and an average price target of $118.86, which forecasts a 18.30% increase in the stock price over the next year. The lowest target is $100 and the highest is $134.
Price Target: $118.86 (+18.30%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HealthEquity stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Buy | 7 | 7 | 8 | 9 | 9 | 8 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 14 | 15 | 15 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Hold Initiates $100 | Hold | Initiates | $100 | -0.47% | Nov 13, 2025 |
| Keybanc | Keybanc | Buy Maintains $125 → $120 | Buy | Maintains | $125 → $120 | +19.44% | Oct 8, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $130 → $134 | Strong Buy | Maintains | $130 → $134 | +33.37% | Sep 3, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $125 → $126 | Buy | Maintains | $125 → $126 | +25.41% | Sep 3, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $125 | Buy | Maintains | $125 | +24.42% | Sep 3, 2025 |
Financial Forecast
Revenue This Year
1.32B
from 1.20B
Increased by 10.27%
Revenue Next Year
1.43B
from 1.32B
Increased by 8.24%
EPS This Year
3.90
from 1.09
Increased by 258.09%
EPS Next Year
4.54
from 3.90
Increased by 16.23%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4B | 1.5B | |
| Avg | 1.3B | 1.4B | |
| Low | 1.3B | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.5% | 16.1% | |
| Avg | 10.3% | 8.2% | |
| Low | 6.4% | 3.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.11 | 4.86 | |
| Avg | 3.90 | 4.54 | |
| Low | 3.67 | 4.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 276.7% | 24.6% | |
| Avg | 258.1% | 16.2% | |
| Low | 236.3% | 7.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.